Ignite Creation Date:
2025-12-26 @ 12:15 PM
Ignite Modification Date:
2026-02-25 @ 9:41 PM
Study NCT ID:
NCT00544700
Status:
TERMINATED
Last Update Posted:
2020-02-20
First Post:
2007-10-13
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Bevacizumab in Treating Patients Who Have Undergone First-Line Therapy for Metastatic Colorectal Cancer
Sponsor:
Swiss Cancer Institute
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2007-11-26
Start Date Type:
ACTUAL
Primary Completion Date:
2013-01-21
Primary Completion Date Type:
ACTUAL
Completion Date:
2019-12-12
Completion Date Type:
ACTUAL
First Submit Date:
2007-10-13
First Submit QC Date:
None
Study First Post Date:
2007-10-16
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2020-02-18
Last Update Post Date:
2020-02-20
Last Update Post Date Type:
ACTUAL